Vivimed Labs Limited: Corporate Insolvency Resolution Process initiated

IBC 17 Aug 2026 · Filed / open· ✓ Verified

Vivimed Labs Limited, a pharmaceutical manufacturing company, has been admitted into Corporate Insolvency Resolution Process by the National Company Law Tribunal (NCLT). The company issued a notice to the stock exchange pursuant to its continuous disclosure obligations under SEBI Listing Obligations and Disclosure Requirements. The CIRP process, governed by the Insolvency and Bankruptcy Code, 2016, will involve identification of a resolution professional, submission of claims by creditors, and efforts to achieve a resolution plan within the statutory timeline.

Why it mattersCIRP filing by a listed pharma entity triggers mandatory disclosure obligations under SEBI LODR and suspension/delisting risk; creditors must file claims within statutory timeline, and resolution professional will manage operations during 180-day (extendable) resolution window.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals